Press Release

CHARLESTON AREA MEDICAL CENTER INTEGRATES SMART PUMP TECHNOLOGY TO ADVANCE PATIENT SAFETY

LAKE FOREST, Ill. Aug. 20, 2015—Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the successful implementation of interoperability between the company's Plum A+™ intravenous (I.V.) infusion devices with Hospira MedNet™ safety software and the electronic medical record (EMR) at all four hospitals in the Charleston Area Medical Center Health System, Inc. (CAMC) in Charleston, W. Va. With this successful implementation, Hospira becomes the first smart pump manufacturer to integrate infusion systems with a third major EMR platform. This advanced technology is also known as I.V.-EMR interoperability.1

"Hospira is proud to be CAMC's chosen partner for I.V.-EMR interoperability," said Cynthia Ansari, vice president, U.S. Marketing and Software, Medical Devices. "With this integration, Hospira becomes the first smart pump manufacturer to successfully integrate with three different, major EMR platforms. With the most live integrated hospitals, Hospira's extensive experience enables optimized system functionality and implementation efficiency.1 Hospira further differentiates through committed partnerships with our customers to provide a tailored solution that addresses today's complex clinical environment."

The connectivity between Hospira infusion devices, Hospira MedNet safety software, and the EMR—or I.V.-EMR interoperability—allows nurses to automatically program infusion pumps with the pharmacy-validated medication order and confirm the order before patient delivery. The infusion information is then automatically sent to the EMR via the secure hospital information system. This enables a pharmacy view displaying currently running infusions to support the timely preparation of subsequent I.V. medication. This advanced system will help to support enhanced patient care, safety and efficiency throughout the CAMC health system, which comprises more than 900 beds.

"At Charleston Area Medical Center, we are dedicated to providing the best patient care through the use of innovative technology like Hospira's I.V.-EMR interoperability," said Ron Moore, chief nursing officer, CMAC. "This solution will help improve medication management processes by connecting the I.V. pump, medication order, patient and record together."

Hospitals that have adopted Hospira's I.V.-EMR interoperability have seen a positive impact to safety, efficiency and costs, such as:

  • Saved an estimated $6.8 million annually in preventable adverse drug events,2
  • Reduced manual infusion pump programing steps from 17 to 7,3
  • Reduced heparin administration errors by 32 percent.3

About Charleston Area Medical Center

Charleston Area Medical Center ("CAMC") is a nonprofit, 908-bed, regional referral and academic medical center with more than 6,000 employees. CAMC is made up off four hospitals: CAMC General Hospital, CAMC Memorial Hospital, CAMC Teays Valley Hospital and CAMC Women and Children's Hospital. CAMC is home to one of the largest heart programs in the United States; the only kidney transplant center in West Virginia; the highest level trauma center; and the only freestanding children's hospital in the state. All medical services are supported by primary care physicians throughout the region who regularly treat their patients at CAMC hospitals or refer them to CAMC for specialty consultation and treatment. Learn more at www.camc.org.

About Hospira

Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill. Learn more at www.hospira.com.

-- Private Securities Litigation Reform Act of 1995 --
A Caution Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Hospira's future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these words or other similar terms or expressions that concern Hospira’s expectations, strategy, plans or intentions. Forward-looking statements in this press release include Hospira's expectations regarding regulatory approvals, clinical trials and the actions of competitors. Hospira's expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including, without limitation, challenges inherent in creating and developing compounds and product candidates and economic, competitive, governmental, regulatory, legal, supply and other factors. Information on these and additional risks affecting Hospira's business and operating results are more fully discussed in the section entitled "Risk Factors" in Hospira’s most recently filed annual report on Form 10-K and any subsequently filed quarterly report on Form 10-Q. The forward-looking statements in this press release are based on information available as of the date hereof, and Hospira disclaims any obligation to update any forward-looking statements, except as required by law.

1 KLAS. Smart Pump/EMR Integration: What Are My Best Options? May 2015, Orem, UT
2 Ford D, Luttrell N. Leadership in patient safety: IV pump auto-programming. Paper presented at: Cerner Health Conference; October 2009; Kansas City, MO
3 Prusch AE, Suess TM, Paoletti RD, Olin ST, Watts SD. Integrating technology to improve medication administration. Am J Health-Syst Pharm. 2011;68(9):835-842.